Fusobacterium canifelinum sp. nov., from the oral cavity of cats and dogs

Systematic and Applied Microbiology
Georg ConradsEllie J C Goldstein

Abstract

Fourteen strains of Gram-negative, anaerobic, fluoroquinolone-resistant, non-sporulating rods were isolated from various infections in cats and dogs, as well as from wounds in humans after cat- or dog-bites. These strains were characterized by sequencing of the 16S-23S rDNA internal transcribed spacer (ITS) regions, 16S rDNA, DNA-DNA hybridization, phylogenetic analysis, and phenotypic tests. The results indicate that the novel strains belong to a distinct species, closely related to Fusobacterium nucleatum. The species Fusobacterium canifelinum sp. nov. is proposed, with strain ATCC BAA 689T as the type strain.

Citations

Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Georg ConradsEllie J C Goldstein
Apr 13, 2011·Clinical Microbiology Reviews·Fredrick M Abrahamian, Ellie J C Goldstein
Nov 10, 2015·Microbial Pathogenesis·Wenling GaoRory M Watt
Jul 3, 2013·Journal of Microbiological Methods·Paulo R G R de AssisMario J Avila-Campos
Nov 7, 2016·Systematic and Applied Microbiology·C De WitteF Haesebrouck
Aug 26, 2017·The Open Dentistry Journal·Smitha ChenicheriAndrew Wood
Nov 17, 2004·International Journal of Systematic and Evolutionary Microbiology
Feb 24, 2011·Expert Review of Anti-infective Therapy·Nicole Thomas, Itzhak Brook
Jul 9, 2017·Current Microbiology·Joong-Ki KookYoung-Hyo Chang
Jun 30, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Michael MillerJoseph D Yao
Nov 7, 2015·Microbiology Spectrum·Ellie J C Goldstein, Fredrick M Abrahamian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.